Neurogene Inc. - Common Stock

Neurogene Inc. - Common Stock Share · US64135M1053 · NGNE (XNAS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Neurogene Inc. - Common Stock
Analyst Grade Summary
gauge-img
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
5
1
0
0
No Price
01.05.2026 20:00
Current Prices from Neurogene Inc. - Common Stock
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
NGNE
USD
01.05.2026 20:00
26,85 USD
0,76 USD
+2,91 %
IEXG: IEX
IEX
NGNE
USD
01.05.2026 19:59
26,85 USD
0,76 USD
+2,91 %
XDUS: Düsseldorf
Düsseldorf
NIRSN53.DUSB
EUR
30.04.2026 17:30
22,40 EUR
-1,40 EUR
-5,88 %
XDQU: Quotrix
Quotrix
NIRSN53.DUSD
EUR
30.04.2026 05:47
22,80 EUR
-
Share Float & Liquidity
Free Float 79,24 %
Shares Float 12,37 M
Shares Outstanding 15,62 M
Company Profile for Neurogene Inc. - Common Stock Share
Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases. Its product candidate includes NGN-401, an investigational AAV9 gene therapy for the treatment of Rett syndrome; and NGN-101 to treat neuronal ceroid lipofuscinosis subtype 5 batten disease. The company is headquartered in New York, New York.

Company Data

Name Neurogene Inc. - Common Stock
Company Neurogene Inc.
Symbol NGNE
Website https://www.neurogene.com
Primary Exchange XNAS NASDAQ
ISIN US64135M1053
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Rachel L. McMinn
Market Capitalization 419 Mio
Country United States of America
Currency USD
Employees 0,1 T
Address 535 W 24th Street, 10011 New York City
IPO Date 2014-03-07

Stock Splits

Date Split
19.12.2023 1:4
25.09.2023 1:5

ID Changes

Date From To
19.12.2023 NLTX NGNE
12.08.2019 AQXP NLTX

Ticker Symbols

Name Symbol
Düsseldorf NIRSN53.DUSB
Frankfurt UU8.F
NASDAQ NGNE
Quotrix NIRSN53.DUSD
More Shares
Investors who hold Neurogene Inc. - Common Stock also have the following shares in their portfolio:
CuraScientific Corp
CuraScientific Corp Share
ISHARES SLI UCITS ETF DE
ISHARES SLI UCITS ETF DE ETF